Involvement of NADPH oxidases in cardiac remodelling and heart failure
- PMID: 17901689
- DOI: 10.1159/000109148
Involvement of NADPH oxidases in cardiac remodelling and heart failure
Abstract
Cardiac remodelling occurs in response to stress, such as chronic hypertension or myocardial infarction, and forms the substrate for subsequent development of heart failure. Key pathophysiological features include ventricular hypertrophy, interstitial fibrosis, contractile dysfunction, and chamber dilatation. Although the molecular mechanisms are complex and not fully defined, substantial evidence now implicates increased oxidative stress as being important. The NADPH oxidase ('Nox') enzymes are a particularly important source of reactive oxygen species that are implicated in redox signalling. This article reviews the evidence for an involvement of NADPH oxidases in different aspects of adverse cardiac remodelling. A better understanding of the roles of this complex enzyme family may define novel therapeutic targets for the prevention of heart failure.
(c) 2007 S. Karger AG, Basel.
Similar articles
-
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.Cardiovasc Res. 2006 Jul 15;71(2):208-15. doi: 10.1016/j.cardiores.2006.03.016. Epub 2006 Mar 27. Cardiovasc Res. 2006. PMID: 16631149 Review.
-
NADPH oxidase and heart failure.Curr Opin Pharmacol. 2006 Apr;6(2):148-53. doi: 10.1016/j.coph.2005.10.008. Epub 2006 Feb 17. Curr Opin Pharmacol. 2006. PMID: 16483850 Review.
-
NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach.Free Radic Biol Med. 2012 Jan 15;52(2):291-7. doi: 10.1016/j.freeradbiomed.2011.10.482. Epub 2011 Nov 3. Free Radic Biol Med. 2012. PMID: 22080085 Review.
-
Oxidative stress and heart failure.Arch Mal Coeur Vaiss. 2003 Mar;96(3):214-21. Arch Mal Coeur Vaiss. 2003. PMID: 12722552 Review.
-
Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.Free Radic Biol Med. 2007 Jul 15;43(2):271-81. doi: 10.1016/j.freeradbiomed.2007.04.021. Epub 2007 Apr 29. Free Radic Biol Med. 2007. PMID: 17603936
Cited by
-
Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction.Circulation. 2009 Apr 14;119(14):1941-9. doi: 10.1161/CIRCULATIONAHA.108.823799. Epub 2009 Mar 30. Circulation. 2009. Retraction in: Circulation. 2023 Sep 26;148(13):e147. doi: 10.1161/CIR.0000000000001083. PMID: 19332462 Free PMC article. Retracted.
-
Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective.Oxid Med Cell Longev. 2017;2017:8214541. doi: 10.1155/2017/8214541. Epub 2017 Oct 24. Oxid Med Cell Longev. 2017. PMID: 29204251 Free PMC article. Review.
-
Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.PLoS One. 2010 Dec 3;5(12):e14227. doi: 10.1371/journal.pone.0014227. PLoS One. 2010. PMID: 21151982 Free PMC article.
-
Overview of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors for the Treatment of Non-diabetic Heart Failure Patients.Cureus. 2021 Aug 12;13(8):e17118. doi: 10.7759/cureus.17118. eCollection 2021 Aug. Cureus. 2021. PMID: 34527497 Free PMC article. Review.
-
Fetal Undernutrition Modifies Vascular RAS Balance Enhancing Oxidative Damage and Contributing to Remodeling.Int J Mol Sci. 2022 Jan 22;23(3):1233. doi: 10.3390/ijms23031233. Int J Mol Sci. 2022. PMID: 35163158 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical